Stem cell treatment for Post-Surgery ED: safety check underway

NCT ID NCT07431008

Recruiting now Disease control Sponsor: Pharmicell Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a safety follow-up for 32 men who previously received an experimental stem cell treatment (Cellgram-ED) for erectile dysfunction after prostate removal due to cancer. Researchers are monitoring tumor markers, serious side effects, and any cancer recurrence over time. The goal is to ensure the treatment does not increase cancer risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ERECTILE DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erectile dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ERECTILE DYSFUNCTION

Contacts and locations

Locations

Asan medical center
RECRUITING

Seoul, South Korea
Ewha womans university medical center
RECRUITING

Seoul, South Korea
Samsung medical center
RECRUITING

Seoul, South Korea
Seoul ST. Mary's hospital
RECRUITING

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.